About Ceribell
Ceribell is a publicly listed company based in Mountain View (United States) founded in 2014 by Chris Chafe. It operates as a portable EEG devices for point-of-care seizure diagnosis are provided. It operates in the Healthcare and Technology sectors. Ceribell has raised $187.52 million across 4 funding rounds from investors including UCB, LivaNova and RA Capital. The company has 281 employees. Its website ceribell.com draws about 31 thousand monthly visits. Ceribell offers products and services including Point-of-Care EEG, Clarity EEG Portal, and EEG University. Its focus areas include High Tech, Brain Computer Interface, Applications and Diagnostics. Its competitors include Kernel, INBRAIN Neuroelectronics, Mynd Analytics, BioSerenity and BrainScope and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Founded in 2014 and based in Mountain View, United States, Ceribell operates in the medical device sector with a focus on neurology diagnostics. Point-of-care EEG systems are developed for seizure detection, including a 10-channel EEG Headband for data recording and a pocket-sized EEG Recorder for real-time signal display, brain activity analysis, and monitoring alerts.
- Headquarters Mountain View, United States
- Employees 281
- Founders Chris Chafe
- Stage Public
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website ceribell.com
- Social LinkedIn X Instagram YouTube
- Legal Name Ceribell, Inc.
- Annual Revenue$89.06 M (USD)36.09as on Dec 31, 2025
- Net Profit-$53.41 M (USD)-32.03as on Dec 31, 2025
- EBITDA-$57.06 M (USD)-47.95as on Dec 31, 2025
- Total Equity Funding$187.52M (USD)
in 4 rounds
- Latest Funding Round$50M (USD), Series C
Sep 2022
- InvestorsUCB
& 9 more
- Employee Count281
Products & Services of Ceribell
Ceribell offers a comprehensive portfolio of products and services, including Point-of-Care EEG, Clarity EEG Portal, and EEG University.
Device for rapid EEG monitoring in critical care settings
Platform for EEG data management and seizure analysis
Online resource for EEG training and guidelines
Apps and channels of Ceribell
its YouTube channel Ceribell has 516 subscribers and 30 videos.
Videos from Ceribell
The most watched videos on Ceribell's YouTube channel, Ceribell (516 subscribers). Click a video to play it here.
More on Ceribell.
Funding Insights of Ceribell
Ceribell has successfully raised a total of $187.52M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $187.52M
- Total Rounds 4
- Last Round Series C — $50M
- First Round $35M
(Sep 2018)
- Investors Count 10
All 4 funding rounds of Ceribell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $50M | Series C | – | Ally Bridge Group | – |
| Apr 2021 | $102.52M | Series C | – | Longitude Capital, The Rise Fund | |
| May 2020 | $20M | Debt – Venture | – | – | |
| Sep 2018 | $35M | Series B | – | Optima Capital, The Rise Fund |
10 investors in total: 10 institutional.
Investors in Ceribell
Ceribell has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include UCB, LivaNova and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and hedge fund investments in healthcare are managed. | – | ally-bridge.com | Hong Kong, China | |
Private equity firm focused on life science sector | – | longitudecapital.com | Menlo Park, United States | |
Sector-agnostic VC investment company investing globally | – | therisefund.com | San Francisco, United States | |
Red Tree Venture Capital is focused on life science investments. | – | redtreevc.com | Redwood City, United States | |
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States | |
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
- | – | optimacapital.pt | - | |
Therapeutic devices for cardiac and neurological conditions are provided worldwide. | 2015 | livanova.com | London, United Kingdom | |
Therapies for immunological and neurological disorders are developed. | 1928 | ucb.com | Brussels, Belgium |
Investor details for Ceribell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ceribell
113 people are tracked at Ceribell (46 in leadership, 67 in team); the tracked headcount is 281.
| Name | Role | Group |
|---|---|---|
Chris Chafe | Co-Founder | Leadership |
Jessy Dorn | VP, Clinical Affairs | Leadership |
Baharan Kamousi | VP, Data Science | Leadership |
Michelle Hofmann | Associate Director Clinical Operations | Leadership |
Kevin Kearney | VP, Account Management Sales | Leadership |
Kurt Kemling | Director Of Digital Marketing | Leadership |
Dave Foehr | VP, Finance | Leadership |
Jane Chao | Co-Founder & CEO | Leadership |
Raymond Woo | CTO | Leadership |
Shaun Gambina | Director Of Revenue Operations | Leadership |
Scott Blumberg | CFO | Leadership |
Trung Pham | Sr. Director, Manufacturing And Facilities Operations | Leadership |
Pauline F. | Chief Of Staff | Leadership |
Asher Cohen | Executive Director Of Product & Design | Leadership |
Michael Cellini | Regional Director, Account Acquistion | Leadership |
Kim McKeon | Head Of People And Culture | Leadership |
Loni Olazaba | Head Of Talent Acquisition | Leadership |
Devon Fetterman | Head Of Contracts | Leadership |
Alyssa Hobson | Regional Account Director | Leadership |
Chad Meyers | Regional Business Director | Leadership |
93 more people are available in the full profile.
Complete people profiles for Ceribell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Ceribell
Ceribell is a publicly listed company on the NASDAQ with ticker symbol CBLL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Oct 2024
- Listed onNASDAQ: CBLL
- Listed entityCeriBell, Inc.
- Exchange sectorHealth technology
- ISINUS15678C1027
- Share price$26.14 (+3.48% on the day) · 2026-10-13
- Market capitalisation$1.00B
- EPS (diluted, trailing year)$-1.76
- Volume (last session)542,698
Financials of Ceribell
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $89.1M | -$53.4M | -$57.1M |
| 2024 | $65.4M | -$40.5M | -$38.6M |
| 2023 | $45.2M | -$29.5M | -$29.2M |
| 2022 | $25.9M | -$37.2M | -$35.5M |
Detailed financial statements for Ceribell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ceribell
4 dated milestones of Ceribell across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Ceribell is founded.
- Funding First funding round of $35.0M.
- Funding Latest funding round, Series C, of $50.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Ceribell
Ceribell has 8 listed competitors in our database, 7 of them funded. They include Kernel, INBRAIN Neuroelectronics, Mynd Analytics, BioSerenity and BrainScope, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kernel.com | 2016 | Los Angeles, United States | $158.25M | – | Multimodal brain measurement technology is developed for neuromedicine applications. | |
| inbrain-neuroelectronics.com | 2019 | Barcelona, Spain | $82.84M | – | AI-based neuroelectronic devices for brain disorder detection are developed. | |
| myndanalytics.com | 1999 | Aliso Viejo, United States | – | 105 | Provider of reference data and analytic tools for clinicians and researchers in psychiatry. | |
| bioserenity.com | 2014 | Paris, France | $120.96M | – | Provider of smart healthcare solutions for sleep and EEG lab management | |
| brainscope.com | 2006 | Bethesda, United States | $62.15M | 38 | Developer of AI-driven EEG platform transforming brain electrical activity into insights | |
| beacon.bio | 2019 | Boston, United States | $27M | 47 | AI-based EEG analysis is provided for healthcare providers. | |
| calahealth.com | 2013 | Stanford, United States | $257.05M | 50 | Wearable neuromodulation devices for essential tremor relief are developed. | |
| rhaeos.com | 2018 | Evanston, United States | $12.8M | 10 | Noninvasive device developed for CSF monitoring and hydrocephalus management. |
Detailed competitors of Ceribell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ceribell
The website of Ceribell (ceribell.com) receives about 31.2K visits a month.
- Monthly visits31.2K
▲ 4.9% vs previous month
Websites whose visitors overlap most with Ceribell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ean.org | 100% | 82.7K | #342,133 | View details | |
| zeto-inc.com | 73% | 11.7K | #2,104,157 | View details | |
| epidiolex.com | 73% | – | #1,010,128 | View details |
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Ceribell (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ceribell
Complete news archive for Ceribell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceribell
Ceribell was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Ceribell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Ceribell is a funded company, having raised a total of $187.52M across 4 funding rounds to date. The company's 1st funding round was a Series B of $35M, raised on Sep 2018.
Ceribell has 281 employees.
Annual revenue of Ceribell is $89.06M as on Dec 31, 2025.
Founded in 2014 and based in Mountain View, United States, Ceribell operates in the medical device sector with a focus on neurology diagnostics. Point-of-care EEG systems are developed for seizure detection, including a 10-channel EEG Headband for data recording and a pocket-sized EEG Recorder for real-time signal display, brain activity analysis, and monitoring alerts.
Ceribell's top competitors include INBRAIN Neuroelectronics, BrainScope and Cala Health.
Ceribell offers Point-of-Care EEG, Clarity EEG Portal, and EEG University.
Yes, Ceribell is publicly traded on NASDAQ under the ticker symbol CBLL.
Ceribell has 10 investors. Key investors include UCB, LivaNova, RA Capital, Horizon Tech Finance, and Ally Bridge Group.